title: Quality of psoriasis care in Germany--results of the national study PsoHealth 2007.
abstract: BACKGROUND
  Many different forms of treatment are available for psoriasis. The German standard is the national AWMF S3 guideline. A national survey on psoriasis care in 2005 indicated deficits in psoriasis care in Germany.
  
  
  OBJECTIVE
  Assessment of the health care situation of patients with psoriasis in Germany.
  
  
  METHODS
  Nation-wide cross-sectional study, in 142 dermatological practices and clinics. The following data were documented: a) Doctor Questionnaire: Treatment, illnesses, clinical characteristics and severity (PASI). b) Patient Questionnaire: Quality of life (QoL), patient relevant therapeutic benefits and satisfaction with the quality of the care. A panel of experts developed and analyzed 8 criteria as indicators of the quality of care.
  
  
  RESULTS
  Of the 2009 evaluated patients, 11.6% suffered from severe psoriasis (PASI > 20) and 27.4% from moderate psoriasis (PASI 10-20). The average PASI value was 10.1, and the DLQI 7.5. 32.2% of patients had a serious reduction in their QoL (DLQI > 10). The share of patients with preceding systemic therapy was 47.3%, in severe psoriasis 62.1%, while 20.1% of the patients had received inpatient treatment. The average number of days absent from work was 3.4. Compared to 2005, all 8 indicators improved.
  
  
  CONCLUSIONS
  Significant numbers of psoriasis patients show serious quality of life reductions and high grades of clinical severity. In comparison to 2005, there has been a notable, nation-wide improvement in psoriasis care.
authors.affiliation: CVderm, Department of Dermatology and Venereology, University Clinics Hamburg-Eppendorf, Germany. m.augustin@derma.de
authors.forename: Matthias
authors.initials: M
authors.lastname: Augustin
authors.forename: Kristian
authors.initials: K
authors.lastname: Reich
authors.forename: Christine
authors.initials: C
authors.lastname: Reich
authors.forename: Sandra
authors.initials: S
authors.lastname: Purwins
authors.forename: Stephan
authors.initials: S
authors.lastname: Jeff Rustenbach
authors.forename: Ines
authors.initials: I
authors.lastname: Schäfer
authors.forename: Marc
authors.initials: M
authors.lastname: Radtke
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D003880:Dermatology / Q000706:statistics & numerical data*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction / Q000706:statistics & numerical data*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D015995:Prevalence; D011565:Psoriasis / Q000453:epidemiology* / Q000628:therapy*; D011785:Quality Assurance, Health Care / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires; D055815:Young Adult